Matches 1 - 6 out of 6
Match Document Document Title
7045152 Treating pulmonary disorders with gaseous agent causing repletion of GSNO  
Pulmonary disorders in which the GSNO pool or glutathione pool in the lung is depleted and where reactive oxygen species in lung are increased, are treated by delivering into the lung as a gas,...
6945247 Method of treating cardio pulmonary diseases with no group compounds  
Treatment of pulmonary disorders associated with hypoxemia and/or smooth muscle constriction and/or inflammation comprises administering into the lungs as a gas compound with an NO group which does...
6676855 Use of a blood-flow decrease preventing agent in conjunction with insufflating gas  
A blood-flow decrease preventing agent is used to negate or reduce the decreased oxygen delivery in abdominal organs caused by insufflating gas. Preferably a gas is delivered into the abdominal...
EP0911316B1 Process for producing alkyl nitrite  
Abstract of EP0911316 An alkyl nitrite can be produced on an industrial scale with a high efficiency and with a low yield of by-products by the process wherein nitrogen oxide-containing feed gas...
6314956 Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders  
Treatment of pulmonary disorders associated with hypoxemia and/or smooth muscle constriction comprises administering into the lungs as a gas a compound with an NO group which does not form NO 2 ...
EP0911316A2 Process for producing alkyl nitrite  
An alkyl nitrite can be produced on an industrial scale with a high efficiency and with a low yield of by-products by the process wherein nitrogen oxide-containing feed gas is brought into an alkyl...
Matches 1 - 6 out of 6